The clinical landscape for managing Attention-Deficit/Hyperactivity Disorder (ADHD) relies heavily on pharmacological options designed to stabilize core symptoms like inattention, impulsivity, and physical hyperactivity. Among the most widely prescribed options is Concerta, an extended-release formulation of methylphenidate hydrochloride. While short-acting stimulants require multiple doses throughout the day, Concerta is known for its specialized delivery mechanism, […]